In-Vitro Study of Homocysteine and Aspirin Effects on Coagulation and Clot Permeability

Document Type : Original Article (s)

Authors

1 Assistant Professor, Department of Biochemistry, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Department of Biochemistry, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

3 Associate Professor, Department of Biochemistry, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

4 Department of Biochemistry, School of Medicine, International Campus, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Abstract

Background: Some studies suggest that increased homocystein in blood leads to alterations in coagulation; however, the precise mechanism is not clear. The aim of this study was to compare different concentrations of homocysteine and aspirin on coagulation parameters and permeability coefficient of clot in the plasma of healthy individuals in vitro.Methods: Different concentrations of homocysteine (50, 100, 200 µM) and aspirin (1, 10, 100 mg/l) were added to the plasma citrate. They were incubated at 37°C for 24 hours. Then, coagulation parameters were analyzed by the turbidimetric procedure at 405 nm and permeability coefficient of clot was determined. The independent samples t-test was utilized to compare the results.Findings: Homocysteine at 200 µM with aspirin 100 mg/l had significant changes in the total coagulation time (820.00 ± 1.15 s), maximum coagulation velocity (0.232 ± 0.003), the permeability coefficient of clot [(1.108 × 10-6) ± 0.151] compared to homocysteine at 200 µM [555.00 ± 12.89, 0.258 ± 0.008, (0.493 × 10-6) ± 0.038, respectively] (P < 0.05). Homocysteine at 200 µM with aspirin 1 mg/l did not significantly change in either parameter (P > 0.05). Homocysteine at 100 µM with aspirin 1 mg/l significantly changed only in the permeability coefficient [(0.787 × 10-6) ± 0.071] compared to homocysteine at 100 µM [(0.636 × 10-6) ± 0.053] (P < 0.05).Conclusion: Aspirin with the dose more than 1 mg/l had more effect on higher concentrations of homocysteine and delayed forming clot by impeding the coagulation. It increased clot permeability, too.

Keywords

References

  1. Xu H, Shi D, Chen K. Atherosclerosis: an integrative East-west medicine perspective. Evid Based Complement Alternat Med 2012; 2012: 148413.
  2. Badimon L, Vilahur G, Padro T. Lipoproteins, platelets and atherothrombosis. Rev Esp Cardiol 2009; 62(10): 1161-78.
  3. Sauls DL, Warren M, Hoffman M. Homocysteinylated fibrinogen forms disulfide-linked complexes with albumin. Thromb Res 2011; 127(6): 576-81.
  4. Kristensen B, Malm J, Nilsson TK, Hultdin J, Carlberg B, Dahlen G, et al. Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. Stroke 1999; 30(5): 974-80.
  5. da Cunha AA, Scherer E, da Cunha MJ, Schmitz F, Machado FR, Lima DD, et al. Acute hyperhomocysteinemia alters the coagulation system and oxidative status in the blood of rats. Mol Cell Biochem 2012; 360(1-2): 205-14.
  6. Phang M, Lazarus S, Wood LG, Garg M. Diet and thrombosis risk: nutrients for prevention of thrombotic disease. Semin Thromb Hemost 2011; 37(3): 199-208.
  7. Malinowska J, Nowak P, Olas B. Comparison of the effect of homocysteine in the reduced form, its thiolactone and protein homocysteinylation on hemostatic properties of plasma. Thromb Res 2011; 127(3): 214-9.
  8. Lauricella AM, Quintana IL, Kordich LC. Effects of homocysteine thiol group on fibrin networks: another possible mechanism of harm. Thromb Res 2002; 107(1-2): 75-9.
  9. Lauricella AM, Quintana I, Castanon M, Sassetti B, Kordich L. Influence of homocysteine on fibrin network lysis. Blood Coagul Fibrinolysis 2006; 17(3): 181-6.
  10. Fatah K, Beving H, Albage A, Ivert T, Blomback M. Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient? Eur Heart J 1996; 17(9): 1362-6.
  11. Smith JB, Willis AL. Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol 1971; 231(25): 235-7.
  12. Ajjan RA, Standeven KF, Khanbhai M, Phoenix F, Gersh KC, Weisel JW, et al. Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system. Arterioscler Thromb Vasc Biol 2009; 29(5): 712-7.
  13. Undas A, Brozek J, Jankowski M, Siudak Z, Szczeklik A, Jakubowski H. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler Thromb Vasc Biol 2006; 26(6): 1397-404.
  14. Mills JD, Ariens RA, Mansfield MW, Grant PJ. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation 2002; 106(15): 1938-42.
  15. Blomback B, Carlsson K, Hessel B, Liljeborg A, Procyk R, Aslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta 1989; 997(1-2): 96-110.
  16. Coppola A, Davi G, De S, V, Mancini FP, Cerbone AM, Di MG. Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 2000; 26(3): 243-54.
  17. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997; 90(1): 1-11.
  18. Olas B, Kolodziejczyk J, Malinowska J. May modifications of human plasma proteins stimulated by homocysteine and its thiolactone induce changes of hemostatic function of plasma in vitro? Gen Physiol Biophys 2010; 29(2): 186-93.
  19. Marchi R, Carvajal Z, Weisel JW. Comparison of the effect of different homocysteine concentrations on clot formation using human plasma and purified fibrinogen. Thromb Haemost 2008; 99(2): 451-2.
  20. Hortin GL. Homocysteine: Clinical Significance and Laboratory Measurement. Lab Med 2006; 37(9): 551-3.
  21. Schroecksnadel K, Frick B, Winkler C, Wirleitner B, Schennach H, Fuchs D. Aspirin downregulates homocysteine formation in stimulated human peripheral blood mononuclear cells. Scand J Immunol 2005; 62(2): 155-60.
  22. Undas A, Brummel-Ziedins KE, Mann KG. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood 2007; 109(6): 2285-92.
  23. Mehmetoglu I, Kurban S. Effects of two different doses of acetylsalicylic acid on serum nitric oxide, asymmetric dimethylarginine, and homocysteine levels in healthy volunteers. Turk J Med Sci 2012; 42(2): 269-74.
Journal of Isfahan Medical School
Volume 31, Issue 262 - Serial Number 262
September and October 2014
Pages 1932-1940

Files

History

  • Receive Date: 01 December 2013
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics